Calibrate
Calibrate raises $100M Series B at $1.3B valuation
Quick Facts
Calibrate: Series B Funding Round
Calibrate has successfully raised $100M in Series B funding, reaching a valuation of $1.3B.
Company Overview
Metabolic health platform
Funding Details
The Series B round was led by Founders Fund, with participation from Threshold Ventures, Optum Ventures, Tiger Global, Redesign Health.
Company Information
- Headquarters: 315 Hudson Street, New York, NY 10013
- Founded: 2020
- Employees: 300+
- Category: HealthTech
Investment
Calibrate plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Founders Fund: Verified investor in Series B
- Threshold Ventures: Verified investor in Series B
- Optum Ventures: Verified investor in Series B
- Tiger Global: Verified investor in Series B
- Redesign Health: Verified investor in Series B
Key Investors
About the Author
Related Company Reports
Zingage raises $12.5M Seed at $60M valuation
Zingage raises $12.5M in Seed at $60M valuation. AI platform for home healthcare coordination and patient engagement...
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
Duos raises $130M Growth Equity at $600M valuation
Duos raises $130M in Growth Equity at $600M valuation. Digital health platform for Medicare-focused patient care...